Literature DB >> 22759349

Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.

Chris O Phillips1, Yasir Syed, Neil Mac Parthaláin, Reyer Zwiggelaar, Tim C Claypole, Keir E Lewis.   

Abstract

Exhaled volatile organic compounds (VOCs) have shown promise in diagnosing chronic obstructive pulmonary disease (COPD) but studies have been limited by small sample size and potential confounders. An investigation was conducted in order to establish whether combinations of VOCs could identify COPD patients from age and BMI matched controls. Breath samples were collected from 119 stable COPD patients and 63 healthy controls. The samples were collected with a portable apparatus, and then assayed by gas chromatography and mass spectroscopy. Machine learning approaches were applied to the data and the automatically generated models were assessed using classification accuracy and receiver operating characteristic (ROC) curves. Cross-validation of the combinations correctly predicted the diagnosis in 79% of COPD patients and 64% of controls and an optimum area under the ROC curve of 0.82 was obtained. Comparison of current and ex smokers within the COPD group showed that smoking status was likely to affect the classification; with correct prediction of smoking status in 85% of COPD subjects. When current smokers were omitted from the analysis, prediction of COPD was similar at 78% but correct prediction of controls was increased to 74%. Applying different analytical methods to the largest group of subjects so far, suggests VOC analysis holds promise for diagnosing COPD but smoking status needs to be balanced.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759349     DOI: 10.1088/1752-7155/6/3/036003

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  13 in total

Review 1.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

Review 2.  Breath Analysis: A Promising Tool for Disease Diagnosis-The Role of Sensors.

Authors:  Maria Kaloumenou; Evangelos Skotadis; Nefeli Lagopati; Efstathios Efstathopoulos; Dimitris Tsoukalas
Journal:  Sensors (Basel)       Date:  2022-02-06       Impact factor: 3.576

3.  Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.

Authors:  Vasiliki Besa; Helmut Teschler; Isabella Kurth; Amir Maqbul Khan; Paul Zarogoulidis; Joerg Ingo Baumbach; Urte Sommerwerck; Lutz Freitag; Kaid Darwiche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-23

Review 4.  Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.

Authors:  Kamila Schmidt; Ian Podmore
Journal:  J Biomark       Date:  2015-03-30

5.  Evaluation of Bio-VOC Sampler for Analysis of Volatile Organic Compounds in Exhaled Breath.

Authors:  Jae Kwak; Maomian Fan; Sean W Harshman; Catherine E Garrison; Victoria L Dershem; Jeffrey B Phillips; Claude C Grigsby; Darrin K Ott
Journal:  Metabolites       Date:  2014-09-29

6.  Short-Term Intra-Subject Variation in Exhaled Volatile Organic Compounds (VOCs) in COPD Patients and Healthy Controls and Its Effect on Disease Classification.

Authors:  Christopher Phillips; Neil Mac Parthaláin; Yasir Syed; Davide Deganello; Timothy Claypole; Keir Lewis
Journal:  Metabolites       Date:  2014-05-09

Review 7.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

Authors:  Kim D G van de Kant; Linda J T M van der Sande; Quirijn Jöbsis; Onno C P van Schayck; Edward Dompeling
Journal:  Respir Res       Date:  2012-12-21

Review 8.  Electronic Noses for Well-Being: Breath Analysis and Energy Expenditure.

Authors:  Julian W Gardner; Timothy A Vincent
Journal:  Sensors (Basel)       Date:  2016-06-23       Impact factor: 3.576

9.  An Expert Diagnostic System to Automatically Identify Asthma and Chronic Obstructive Pulmonary Disease in Clinical Settings.

Authors:  Almir Badnjevic; Lejla Gurbeta; Eddie Custovic
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

Review 10.  Personalized medicine for patients with COPD: where are we?

Authors:  Frits Me Franssen; Peter Alter; Nadav Bar; Birke J Benedikter; Stella Iurato; Dieter Maier; Michael Maxheim; Fabienne K Roessler; Martijn A Spruit; Claus F Vogelmeier; Emiel Fm Wouters; Bernd Schmeck
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.